Vitamin D and Perimenopause: A Crucial Connection

Falling estrogen levels during perimenopause directly impair your body’s ability to use vitamin D, even if your intake stays the same. Estrogen helps activate vitamin D receptors throughout your tissues, so as estrogen fluctuates and declines in the years before menopause, vitamin D’s effectiveness drops in lockstep. This creates a situation where a nutrient already commonly deficient in women becomes even harder to maintain at adequate levels, right when your bones, mood, cardiovascular system, and pelvic floor need it most.

Why Estrogen and Vitamin D Are Linked

Vitamin D does not work on its own. It needs receptors (called VDRs) scattered across your cells to do anything useful. Estrogen has a direct role in producing and maintaining those receptors. Animal studies have shown that when estrogen is removed (by removing the ovaries in lab animals), the number of vitamin D receptors in intestinal tissue drops sharply. Giving estrogen back roughly doubled the receptor levels and restored the tissue’s ability to respond to vitamin D.

The same pattern plays out in bone. In mice whose ovaries were removed, the percentage of bone-building cells that expressed vitamin D receptors fell significantly, and estrogen replacement brought those numbers back up in both young and old animals. In older mice, the recovery was even more pronounced, with VDR-expressing bone cells jumping from 48% to 85% after estrogen was restored.¹ In the gut, estrogen doubled VDR messenger RNA and increased the actual receptor protein by 1.5 to 2 times, boosting the intestine’s ability to absorb calcium in response to vitamin D.²

This means perimenopause creates a kind of double jeopardy. Your estrogen is declining erratically, which reduces your vitamin D receptor expression. At the same time, body composition shifts common in midlife (increased fat mass, decreased lean mass) can further lower circulating vitamin D because the vitamin gets sequestered in fat tissue. The result is that women who were borderline-adequate on vitamin D before perimenopause can slip into outright deficiency without changing a single thing about their diet or sun exposure.

What Happens to Your Bones

Bone loss accelerates around the menopausal transition. Without intervention, women can lose bone mineral density at roughly 0.4% per year, and the rate tends to spike in the first several years after menstruation stops.³ Vitamin D’s primary bone-related job is enabling calcium absorption in the gut, so when your receptors are downregulated due to low estrogen, you absorb less calcium from the same diet. That calcium has to come from somewhere, and your skeleton becomes the source.

A study of over 72,000 postmenopausal women, tracked for 18 years, found that adequate vitamin D intake was associated with a reduced risk of hip fractures, and meta-analyses have supported the idea that combined calcium and vitamin D supplementation helps prevent osteoporotic fractures in this population.⁴ The evidence is clearest when calcium and vitamin D are taken together rather than vitamin D alone.

There is a wrinkle worth knowing. In healthy perimenopausal women, researchers found a consistent inverse relationship between the active form of vitamin D (1,25-dihydroxyvitamin D) and bone mineral density at the spine and hip. Higher levels of this active form were associated with increased markers of bone turnover.⁵ This does not mean vitamin D is harmful to bone. It reflects the fact that when calcium intake is low or absorption is impaired, your body ramps up the active form of vitamin D to pull more calcium from the gut, and if that fails, it pulls calcium from bone. The solution is not to avoid vitamin D but to make sure calcium supply keeps pace.

Hot Flashes, Mood, and Fatigue

Vasomotor symptoms like hot flashes are among the most disruptive experiences of perimenopause, and vitamin D status appears to have a measurable relationship with their severity. In a study comparing postmenopausal women who experienced hot flashes with those who did not, women with hot flashes had significantly lower vitamin D levels. After adjusting for age and how long ago menopause occurred, each one-unit decrease in vitamin D increased the risk of hot flashes by about 6%.⁶ The mechanism is not fully mapped, but vitamin D receptors are present in the hypothalamus, which regulates body temperature, and low vitamin D may contribute to the dysregulation of thermoregulatory controls that estrogen withdrawal already destabilizes.

Mood and energy are also affected. A placebo-controlled trial specifically in perimenopausal women with vitamin D deficiency found significant improvements in both fatigue and mood among those who received vitamin D supplementation compared with placebo.⁷ Depression rates climb during perimenopause for many women, and while vitamin D is not a replacement for mental health treatment, correcting a deficiency appears to be a low-risk way to improve baseline mood and energy levels during a period when both tend to suffer.

A prospective cohort study added another layer by finding that women with vitamin D levels below 20 ng/mL had more severe menopausal symptoms overall, lower estrogen, higher FSH, poorer bone density, and reduced quality of life compared with women whose levels were above 30 ng/mL.⁸ That does not prove that fixing the deficiency would reverse all those outcomes, but it does establish that low vitamin D and a harder menopausal experience tend to travel together.

Pelvic Floor and Bladder Health

This is one of the less discussed areas where vitamin D matters during and after the menopausal transition. A meta-analysis of observational studies found that women with pelvic floor disorders had significantly lower vitamin D levels than healthy women.⁹ One study put numbers on it: women with pelvic floor disorders had average vitamin D levels around 13 ng/mL compared with about 18 ng/mL in women without these issues, and the association held after adjusting for age. Women who had been postmenopausal for more than five years had about three times the odds of pelvic floor disorders.¹⁰

Vitamin D receptors are expressed in pelvic floor muscles, and the vitamin plays a role in muscle function generally. When deficiency weakens those muscles, symptoms like stress urinary incontinence and pelvic organ prolapse become more likely. In one study, pelvic floor muscle strength was significantly lower in women with vitamin D deficiency, though interestingly, their symptom questionnaire scores were similar to those of non-deficient women, suggesting that the muscle weakness may precede noticeable symptoms.¹¹ This is worth flagging because it means a woman could have measurably weaker pelvic floor muscles without realizing it until the problem progresses.

Ovarian Reserve and the AMH Question

Anti-Müllerian hormone (AMH) is a marker that roughly tracks how many eggs you have left, and it declines as you approach menopause. Some research has suggested that vitamin D levels and AMH are connected. A cross-sectional study of women in their late reproductive years found a positive correlation between vitamin D and AMH levels in women over 40.¹² And in women with diminished ovarian reserve, vitamin D supplementation was associated with increases in both AMH and antral follicle count, alongside a decrease in FSH (a hormone that rises as ovarian reserve drops).¹³

Before getting too excited about this, the bigger picture is muddier. A meta-analysis pooling data from over 2,400 women found no significant difference in AMH levels between women with sufficient vitamin D and those with deficiency, and no significant correlation between the two overall.¹⁴ This is one of those areas where individual studies show promising signals, but the aggregated evidence does not clearly support the idea that vitamin D supplementation can meaningfully slow ovarian aging. It may still matter for women who are already deficient, but there is no strong case that vitamin D can “preserve fertility” in the way some wellness marketing implies.

Cardiovascular and Metabolic Ripple Effects

Cardiovascular risk rises during and after the menopausal transition, and vitamin D has been studied as a potential factor. One finding worth understanding involves parathyroid hormone (PTH), which your body produces more of when vitamin D is low. In postmenopausal women with vitamin D insufficiency, researchers found that while vitamin D levels were loosely correlated with arterial stiffness, the real independent predictor was elevated PTH. Women with high PTH levels had a three- to five-fold greater chance of increased aortic stiffness, independent of other cardiovascular risk factors.¹⁵ In other words, the cardiovascular danger may not be low vitamin D per se, but the chain reaction it triggers by pushing PTH levels up.

On the metabolic side, the picture is more complicated. When researchers looked at vitamin D’s relationship to metabolic syndrome in menopausal women, the initial associations looked promising in raw analyses, but after adjusting for body weight and lifestyle factors, the only independent link that held was between vitamin D and lower fasting glucose levels. Body mass index was the only independent predictor of metabolic syndrome itself. This is a useful reality check: vitamin D is not a metabolic silver bullet, and the apparent connection between deficiency and metabolic syndrome may largely reflect the fact that both tend to track with higher body weight.

Thyroid Connections

Hashimoto’s thyroiditis, an autoimmune thyroid condition, is far more common in women and often worsens or first appears around the menopausal transition. Vitamin D plays a role in regulating the immune system, and deficiency (below 20 ng/mL) has been linked to higher thyroid antibody levels. Supplementation at moderate doses in the range of 2,000 to 4,000 IU per day has been shown to reduce thyroid antibodies by roughly 15 to 30%, but only in a narrow window: women who are still in the early antibody-positive stage rather than full-blown hypothyroidism, and who have baseline vitamin D levels below 20 ng/mL.¹⁶ If you are perimenopausal and have Hashimoto’s or elevated thyroid antibodies, checking and correcting vitamin D status is one of the simpler interventions available, though it will not replace thyroid medication if you need it.

Supplementation Practicalities

If you are going to supplement, the form matters. Vitamin D3 (cholecalciferol) is significantly more effective than D2 (ergocalciferol) at raising blood levels. A meta-analysis found that D3 raised total vitamin D levels by about 16 nmol/L more than D2 did, and was also better at lowering PTH.¹⁷ This held true regardless of dose or how the supplement was delivered. Most over-the-counter vitamin D supplements are already D3, but it is worth checking, especially if you are vegetarian (D2 is plant-derived, while D3 traditionally comes from animal sources, though lichen-based D3 is now available).

Vitamin K2 is increasingly recognized as an important companion to vitamin D, particularly for bone and cardiovascular health. Vitamin D increases calcium absorption, but vitamin K2 helps direct that calcium into bones rather than allowing it to accumulate in arteries. A review of clinical studies in postmenopausal women concluded that combined vitamin D and K supplementation may benefit both bone and cardiovascular health more than either alone.¹⁸ One trial demonstrated the practical scale of this: over 24 months, postmenopausal women taking both vitamins K2 and D3 saw bone mineral density increase by about 5%, while those taking K2 alone saw essentially no change.¹⁹

One caution for women on menopausal hormone therapy: a large French cohort study found that the relationship between vitamin D supplementation and breast cancer risk differed depending on whether women were using hormone therapy. Among women who had ever used hormone therapy, current vitamin D supplementation was associated with a 26% lower breast cancer risk. Among women who had never used hormone therapy, there was no clear benefit.²⁰ This is an observational finding, not proof of cause and effect, but it suggests that the interplay between vitamin D, estrogen, and breast tissue is more nuanced than simple “take D, reduce risk” messaging implies.

Genetics and Individual Variation

Not every woman responds to vitamin D supplementation the same way, and part of the reason is genetic. Variations in the vitamin D receptor gene influence how efficiently your body uses the vitamin D it has. In a study of perimenopausal Japanese women, those with one version of a VDR gene variant showed a positive correlation between increased calcium intake and improved spine bone density over three years, while women with a different version of the same gene showed a negative correlation.²¹ These genetic differences do not mean supplementation is useless for some women, but they help explain why two women with identical blood levels and similar diets can have very different bone outcomes.

This is an area where the research is still catching up. Consumer genetic tests can identify some VDR variants, but translating those results into specific dose recommendations is not yet reliable. The practical takeaway for now is that if you have been supplementing consistently and your blood levels are adequate but you still have bone loss or persistent symptoms associated with deficiency, your VDR genetics might be part of the story, and it is worth discussing with a clinician rather than simply doubling your dose.

Skin Changes During the Transition

Collagen loss accelerates during and after menopause, contributing to thinner, less elastic skin. Vitamin D is involved in skin cell turnover and repair, and some emerging evidence connects supplementation with measurable skin improvements. In a randomized controlled study of menopausal women, a group receiving calcium, vitamin D, and collagen saw skin hydration improve by 23% and skin elasticity improve by about 9% over six months. Interestingly, a group receiving just calcium and collagen without vitamin D also improved in elasticity (by about 12%), suggesting collagen does most of the heavy lifting for skin, but the addition of vitamin D contributed to hydration specifically.²² This is a single study and should be interpreted cautiously, but it does suggest that the benefits of correcting vitamin D deficiency during perimenopause extend beyond the commonly discussed domains of bone and mood.

Vitamin D’s role in skin is largely about supporting the barrier function and modulating inflammation. Given that many perimenopausal women notice skin becoming drier, more reactive, or slower to heal, maintaining adequate vitamin D is plausibly part of a broader strategy alongside hydration and sun protection. It is not a substitute for topical skincare, but it supports the substrate that topical products work on.